Ravinder Heights Ltd
Ravinder Heights Ltd Live Price Chart
Ravinder Heights Ltd Technicals
| 20 Day | ₹ 47.686 |
| 50 Day | ₹ 50.774 |
| 100 Day | ₹ 52.131 |
| 200 Day | ₹ 52.348 |
| 20 Day | ₹ 47.610 |
| 50 Day | ₹ 52.445 |
| 100 Day | ₹ 54.640 |
| 200 Day | ₹ 50.955 |
Ravinder Heights Ltd Performance
| Previous Close | ₹ 46.68 |
| High | ₹ 49.92 |
| Volume | 32071 |
| 52W Range | ₹ 38.15 - ₹ 71.36 |
| Open | ₹ 47 |
| Low | ₹ 47 |
| Market Cap | ₹ 349 Cr |
Ravinder Heights Ltd Fundamentals
| ROCE | -0.197 |
| P/E Ratio | -718.570 |
| P/B Ratio | 0.850 |
| Industry P/E | 0.850 |
| Debt to Equity | 55.661 |
| ROE | -0.110 |
| EPS | -0.070 |
| Dividend Yield | 0.000 |
| Book Value | 59.101 |
| Face Value | 1.000 |
Ravinder Heights Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 1.4951 | 1.4783 | 1.475 | 1.4353 | 1.1169 |
| Total Expenses | 2.2119 | 1.9758 | 2.3965 | 1.7196 | 1.8201 |
| Profit After Tax | -0.3829 | -0.2829 | -0.7099 | -0.1639 | -0.1282 |
Ravinder Heights Ltd Shareholding Pattern
| Promoter Holdings | 74.744 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 16.375 % |
| Others - | 8.880 % |
About Ravinder Heights Ltd
History of Ravinder Heights Ltd
Ravinder Heights Limited was incorporated on April 15, 2019 as a wholly owned subsidiary of Panacea Biotec Limited. The Company is engaged in the business of the Real Estate. It undertake the business of acquisition, construction, development of townships built-up infrastructure, housing, commercial premises, hotels, resorts, hospital, educational institution, recreational facilities, city and regional level infrastructure. In 2019-20, the Real Estate Business Undertaking of Panacea Biotec Limited got demerged with and into the Company as a going concern basis, through the Scheme of Arrangement in December, 2020. Accordingly, the Shareholders of Panacea Biotec Limited were allotted one fully paid-up equity share of Re. 1/- each in the Company, for every one fully paid-up equity share of Re. 1/- each held by them in Panacea Biotec Limited. Simultaneously, the Company ceased to be a subsidiary of Panacea Biotec Limited. ...
